StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.99−0.25 (-4.77%)

Close on Nov 17, 2026Market cap $489.46MP/E –Yield –

aTYR PHARMA cash

Cash and short-term investments held at the end of each period.

aTYR PHARMA's cash was $57.42M at Jun 30, 2026. For fiscal 2025 it was $78.69M, up 9.1% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is $107.91M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$78.69M+9.1%
FY2024Dec 31, 2024$72.13M-26.5%
FY2023Dec 31, 2023$98.17M+48.4%
FY2022Dec 31, 2022$66.15M-38.7%
FY2021Dec 31, 2021$107.91M+240.5%
FY2020Dec 31, 2020$31.69M+1.7%
FY2019Dec 31, 2019$31.14M-37.1%
FY2018Dec 31, 2018$49.55M-41.8%
FY2017Dec 31, 2017$85.12M+18.0%
FY2016Dec 31, 2016$72.15M-24.5%
FY2015Dec 31, 2015$95.54M+502.6%
FY2014Dec 31, 2014$15.85M-56.5%
FY2013Dec 31, 2013$36.46M+892.0%
FY2012Dec 31, 2012$3.68M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$57.42M-28.5%
Q1 FY2026Mar 31, 2026$66.51M-12.9%
Q4 FY2025Dec 31, 2025$78.69M+9.1%
Q3 FY2025Sep 30, 2025$85.15M+29.0%
Q2 FY2025Jun 30, 2025$80.35M+2.4%
Q1 FY2025Mar 31, 2025$76.35M-9.6%
Q4 FY2024Dec 31, 2024$72.13M-26.5%
Q3 FY2024Sep 30, 2024$65.99M-35.4%
Q2 FY2024Jun 30, 2024$78.48M-27.7%
Q1 FY2024Mar 31, 2024$84.50M-26.1%
Q4 FY2023Dec 31, 2023$98.17M+48.4%
Q3 FY2023Sep 30, 2023$102.13M+32.0%
Q2 FY2023Jun 30, 2023$108.58M+22.6%
Q1 FY2023Mar 31, 2023$114.39M+15.9%
Q4 FY2022Dec 31, 2022$66.15M-38.7%
Q3 FY2022Sep 30, 2022$77.37M-33.5%
Q2 FY2022Jun 30, 2022$88.55M+101.0%
Q1 FY2022Mar 31, 2022$98.67M+94.8%
Q4 FY2021Dec 31, 2021$107.91M+240.5%
Q3 FY2021Sep 30, 2021$116.35M+221.9%
Q2 FY2021Jun 30, 2021$44.06M+6.3%
Q1 FY2021Mar 31, 2021$50.64M+1.6%
Q4 FY2020Dec 31, 2020$31.69M+1.7%
Q3 FY2020Sep 30, 2020$36.15M-5.0%
Q2 FY2020Jun 30, 2020$41.43M-2.3%
Q1 FY2020Mar 31, 2020$49.83M+15.8%
Q4 FY2019Dec 31, 2019$31.14M-37.1%
Q3 FY2019Sep 30, 2019$38.06M-32.0%
Q2 FY2019Jun 30, 2019$42.40M-34.1%
Q1 FY2019Mar 31, 2019$43.02M-41.9%
Q4 FY2018Dec 31, 2018$49.55M-41.8%
Q3 FY2018Sep 30, 2018$55.96M-38.1%
Q2 FY2018Jun 30, 2018$64.33M+12.4%
Q1 FY2018Mar 31, 2018$74.10M+19.6%
Q4 FY2017Dec 31, 2017$85.12M+18.0%
Q3 FY2017Sep 30, 2017$90.38M+28.1%
Q2 FY2017Jun 30, 2017$57.22M–
Q1 FY2017Mar 31, 2017$61.93M–
Q4 FY2016Dec 31, 2016$72.15M–
Q3 FY2016Sep 30, 2016$70.53M–

More aTYR PHARMA figures

See a number that looks wrong?